Fabrication and evaluation of polymeric films for transdermal delivery of pinacidil

Pharmazie

Volumn 59, Issue 8, 2004, Pages 631-635

  Aqil, Mohd ^a,b   Ali, A ^a   Sultana, Y ^a   Najmi, A K ^a  

^a HAMDARD UNIVERSITY   (India)

^b HAMDARD UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EUDRAGIT; GLASS; PHTHALIC ACID DIBUTYL ESTER; PINACIDIL; POLYMER; POLYVINYL ACETATE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG CONTENT UNIFORMITY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG POLYMER INTERACTION; DRUG RELEASE; DRUG STABILITY; DRUG STORAGE; ENVIRONMENTAL TEMPERATURE; FILM; FLEXIBILITY; FRAGILITY; HUMIDITY; MOISTURE; MOISTURE VAPOR TRANSMISSION; MOLECULAR INTERACTION; NONHUMAN; PHYSICAL CHEMISTRY; POLYMERIC FILM; RABBIT; RAT; ROUGHNESS; SKIN IRRITATION; SKIN PERMEABILITY; STOICHIOMETRY; SURFACE PROPERTY; TENSILE STRENGTH; THERMOSTABILITY; THICKNESS; TRANSDERMAL DRUG ADMINISTRATION; TRANSPARENCY; VAPOR; WATER ABSORPTION; WATER ABSORPTION CAPACITY; WEIGHT;

ABSORPTION; ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIHYPERTENSIVE AGENTS; CHEMISTRY, PHARMACEUTICAL; CHEMISTRY, PHYSICAL; CHROMATOGRAPHY, THIN LAYER; DRUG DELIVERY SYSTEMS; DRUG STABILITY; DRUG STORAGE; EDEMA; ERYTHEMA; FORMALDEHYDE; IRRITANTS; PINACIDIL; PLASTICIZERS; POLYMERS; POLYVINYLS; RABBITS; RATS;

EID: 4143089178     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Aqil M, Ali A (2002) Monolithic matrix type transdermal drug delivery systems of pinacidil monohydrate: In-vitro characterization. Eur J Pharm Biopharm 54: 161-164.
2. Baichwal MR, Deshpande SG, Singh PK, Venkitachalam P (1988) Studies on polymeric films for transdermal use. Ind J Pharm Sci 50: 153-156.
3. Bhalla HL, Toddywala RD (1988) Transdermal films of ephedrine. Drug Dev Ind Pharm 14: 119-131.
4. Bonina FP, Carellii V, Cols GD, Montenegro L, Nannipieri E (1993) Vehicle effects on in vitro skin permeation of and stratum corneum affinity for model drugs caffeine and testosterone. Int J Pharm 100: 41-47.
5. Corbo M, Liu JC, Chein YW (1990) Bioavailability of propranolol following oral and transdermal administration in rabbits. J Pharm Sci 79: 584-587.
6. nd ed., New York, p. 523-547.
7. Devi VK, Saisivam S, Maria GR, Deepti PU (2003) Design and evaluation of matrix diffusion controlled transdermal patches of verapamil hydrochloride. Drug Dev Ind Pharm 29: 495-503.
8. Dias VC, Tendler B, Oparil S, Reilly PA, Snarr P, White WB (1999) Clinical experience with transdermal clonidine in African-American and Hispanic-American patients with hypertension: evaluation from a 12 week prospective, open label, clinical trial in community based clinics. Am J Ther 6: 19-24.
9. Franz T (1975) Percutaneous absorption. On the relevance of in vitro data. J Invest Dermatol 64: 190-195.
10. Ghosh TK, Adir J, Xiang SL, Onyilofur S (1995) Transdermal delivery of metoprolol II: In-vitro skin permeation and bioavailability in hairless rats. J Pharm Sci 84: 158-160.
11. Iordanskii AL, Feldstein MM, Markin VS, Hadgraft J, Plate NA (2000) Modeling of the drug delivery from a hydrophilic transdermal therapeutic system across polymer membrane. Eur J Pharm. Biopharm. 49: 287-93.
12. Jain SK, Chourasia MK, Sabitha M, Jain R, Jain AK, Ashawat M, Jha AK (2003) Development and characterization of transdermal drug delivery systems for diltiazem hydrochloride. Drug Deliv 10: 169-177.
13. Kotiyan PN, Vavia PR (2001) Eudragits: Role as crystallization inhibitors in drug-in-adhesive transdermal systems of estradiol. Eur J Pharm Biopharm 52: 173-180.
14. Krishna R, Pandit JK (1994) Transdermal delivery of propranolol. Drug Dev Ind Pharm. 20: 2459-2465.
15. Minghetti P, Cilurzo F, Casiraghi A, Molla FA, Montanari L (1999) Dermal patches for the controlled release of miconazole: influence of the drug concentration on the technological characteristics. Drug Dev Ind Pharm. 25: 679-84.
16. Rafiee-Tehrani M, Safai-Nikui N, Peteriet H, Beckert T (2001) Acrylic resins as rate controlling membranes in novel formulation of a nine-day 17-estradiol transdermal delivery system: in vitro and release modifier evaluation. Drug Dev Ind Pharm. 27: 431-437.
17. Ramarao P, Diwan PV (1998) Formulation and in vitro evaluation of polymeric films of diltiazem hydrochloride and indomethacin for transdermal administration. Drug Dev Ind Pharm 24: 327-336.
18. Samanta MK, Dubey R, Suresh B (2003) Transdermal drug delivery system of haloperidol to overcome self-induced extrapyramidal syndrome. Drug Dev Ind Pharm. 29: 405-415.
19. Shin SC, Lee HJ (2002) Controlled release of triprolidine using ethylenevinyl acetate membrane and matrix systems. Eur J Pharm Biopharm 54: 201-206.
20. Singh SK, Durrani MJ, Reddy IK, Khan MA (1996) Effect of permeation enhancers on the release of ketoprofen through transdermal drug delivery systems. Pharmazie 51: 741-744.
21. Tipre DN, Vavia PR (2002) Formulation, optimization and stability study of transdermal therapeutic system of nicorandil. Pharm Dev Technol 7: 325-332.
22. Tipre DN, Vavia PR (2003) Acrylate-based transdermal therapeutic system of nitrendipine. Drug Dev Ind Pharm 2: 71-78.
23. Toon S, Hopkins KJ, Aarons L, Rowland M (1989) Rate and extent of absorption of clonidine from a transdermal therapeutic system. J Pharm Pharmacol 41: 17-21.
24. USP (1999) The United States Pharmacopoeia: 23rd rev., Rockville, MD, p. 1796-1799.
25. Valenta C, Dabic T (2001) Effect of urea and pantothenol on the permeation of progesterone through excised rat skin from polymer matrix systems. Drug Dev Ind Pharm 27: 57-62.
26. Verma PRP, Iyer SS (2000) Transdermal delivery of propranolol using mixed grades of eudragits: Design and in vitro and in vivo evaluation. Drug Dev Ind Pharm 26: 471-476.